We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BHQ® Patent Issued to Biosearch Technologies
News

BHQ® Patent Issued to Biosearch Technologies

BHQ® Patent Issued to Biosearch Technologies
News

BHQ® Patent Issued to Biosearch Technologies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BHQ® Patent Issued to Biosearch Technologies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biosearch Technologies, Inc. (BTI) has announced that it has been awarded U.S. Patent No. 7,019,129 covering the Black Hole Quencher® series of dark quenchers.

BHQ® quenchers are used routinely in a variety of fluoresence quenching applications including multiplex real-time, quantitative PCR and assays requiring FRET-quenched peptides.

The patent detailing this technology is titled "Dark quenchers for donor-acceptor energy transfer" and was developed wholly at Biosearch by Ron Cook, Matt Lyttle and Daren Dick.

Since their commercial introduction in 2000 at the Miami TIGR meeting, the BHQ quenchers have become the most frequently requested dark quenchers for FRET-based applications.

Importantly, they provide significant advantages over other quenchers: they are completely non-fluorescent, they quench across the entire visible spectrum and into the near IR and they are available as amidites, CPGs, carboxylic acids and succinimide esters for both DNA and peptide labeling.

These factors and others led to their early evaluation and commercial licensing by major custom oligonucleotide synthesis houses wanting to offer their end-user customers the advanced fluoresence quenching system available.

Biosearch now licenses the BHQ technology to major custom oligo providers in the U.S. and Europe and has recently begun licensing to custom oligo suppliers in Asia.

As the incorporation of BHQ labels into dual-labled probes for real-time qPCR has expanded and their use validated, the BHQs are now being licensed by a variety of companies both in the U.S. and abroad for incorporation into a wide range of commercial kits.

These range from basic research use only (RUO) kits to clinically important, fully validated human in vitro diagnostic kits.

In addition, the BHQs are now being incorporated into applications as diverse as veterinary and agriculture IVD, national biodefense monitoring and testing applications, aquaculture pathogen testing and the world’s first PCR-based test for monitoring of undesirable wine fermentation microbes.

In very real terms, the Black Hole Quencher dyes have become the world-wide standard for dark quenchers used in fluoresence-quenched assays.

DNA probes labeled with the BHQ technology are available from Biosearch Technologies and from Biosearch-licensed suppliers located in major markets around the globe.

Advertisement